Revolution Medicines, Inc. (RVMD) Misses Q4 EPS by 28c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q4 EPS of ($1.86), $0.28 worse than the analyst estimate of ($1.58).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Active options: MSFT PLTR META GOOGL SOFI MSTR IREN AMC IBM SMCI HOOD AMD
• Ross Stores (ROST) call put ratio 1 call to 1 put as share price down 3%